Search Results - "Combs, D W"

Refine Results
  1. 1

    γ-Aminobutyrate-A Receptor Modulation by 3-Aryl-1-(arylsulfonyl)- 1,4,5,6-tetrahydropyridazines by Rybczynski, Philip J, Combs, Donald W, Jacobs, Kimberly, Shank, Richard P, Dubinsky, Barry

    Published in Journal of medicinal chemistry (01-07-1999)
    “…A series of 3-aryl-1-(arylsulfonyl)-1,4,5,6-tetrahydropyridazine allosteric modulators of the GABAA receptor was synthesized, and biological activity was…”
    Get full text
    Journal Article
  2. 2

    6-Benzoxazinylpyridazin-3-ones: potent, long-acting positive inotrope and peripheral vasodilator agents by Combs, Donald W, Rampulla, Marianne S, Bell, Stanley C, Klaubert, Dieter H, Tobia, Alfonso J, Falotico, Robert, Haertlein, Barbara, Lakas-Weiss, Constance, Moore, John B

    Published in Journal of medicinal chemistry (01-01-1990)
    “…A series of 6-benzoxazinylpyridazin-3-ones was prepared and evaluated for inhibition of cardiac phosphodiesterase (PDE) fraction III in vitro and for positive…”
    Get full text
    Journal Article
  3. 3

    Bemoradan--a novel inhibitor of the rolipram-insensitive cyclic AMP phosphodiesterase from canine heart tissue by Moore, Jr, J B, Combs, D W, Tobia, A J

    Published in Biochemical pharmacology (15-07-1991)
    “…Canine cardiac muscle contains a type IV cyclic AMP (cAMP) phosphodiesterase (PDE) that is composed of two subtypes. One subtype is sensitive to rolipram…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Synthesis and cardiotonic activity of a series of substituted 4-alkyl-2(1H)-quinazolinones by Bandurco, Victor T, Schwender, Charles F, Bell, Stanley C, Combs, Donald W, Kanojia, Ramesh M, Levine, Seymour D, Mulvey, Dennis M, Appollina, Mary A, Reed, Marianne S

    Published in Journal of medicinal chemistry (01-08-1987)
    “…The synthesis, cardiac fraction III cyclic nucleotide phosphodiesterase (PDE-III) inhibition, and positive inotropic activity of a series of…”
    Get full text
    Journal Article
  8. 8

    Parallel synthesis of 2-alkoxy and 2-acyloxyphenylpropyl amides and amines using dihydrocoumarins as versatile synthons. Application of a novel resin quench-capture method by Bussolari, Jacqueline C., Rehborn, Diana C., Combs, Donald W.

    Published in Tetrahedron letters (12-02-1999)
    “…A solution phase synthesis for the preparation of libraries of 2-substituted phenylpropyl amines and amides was accomplished using dihydrocoumarins as a useful…”
    Get full text
    Journal Article
  9. 9

    Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors by Combs, Donald W, Reese, Kimberly, Cornelius, Lyndon A. M, Gunnet, Joseph W, Cryan, Ellen V, Granger, Kay S, Jordan, Jerold J, Demarest, Keith T

    Published in Journal of medicinal chemistry (01-12-1995)
    “…A novel series of nonsteroidal heterocycles was discovered which display cell-type selective, high-affinity (nanomolar) binding to the progesterone receptors…”
    Get full text
    Journal Article
  10. 10

    Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail by Allan, G F, Lombardi, E, Haynes-Johnson, D, Palmer, S, Kiddoe, M, Kraft, P, Campen, C, Rybczynski, P, Combs, D W, Phillips, A

    Published in Molecular endocrinology (Baltimore, Md.) (01-10-1996)
    “…Progesterone receptor antagonists are a promising class of therapeutic drugs indicated for the treatment of a variety of reproductive conditions. Understanding…”
    Get full text
    Journal Article
  11. 11

    Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides by Combs, D W, Rampulla, M S, Russell, R K, Rampulla, R A, Klaubert, D H, Ritchie, D, Meeks, A S, Kirchner, T

    Published in Drug design and delivery (01-10-1990)
    “…A synthetic program of rational drug design was undertaken to develop a series of quinazoline-3-oxides as pulmonary-selective inhibitors of ovalbumin-induced,…”
    Get more information
    Journal Article
  12. 12

    Heteroatom analogs of bemoradan: chemistry and cardiotonic activity of 1,4-benzothiazinylpyridazinones by Combs, Donald W, Rampulla, Marianne S, Demers, James P, Falotico, Robert, Moore, John B

    Published in Journal of medicinal chemistry (01-01-1992)
    “…A series of close analogues of the potent, long-acting cardiotonic bemoradan (2a) was synthesized and examined in both in vitro and in vivo test systems…”
    Get full text
    Journal Article
  13. 13

    2,6-Dihydroxy-4H-pyridazino[3,4,5-de]quinazoline: A new ring system by Combs, Donald W., Rampulla, Marianne S.

    Published in Journal of heterocyclic chemistry (01-11-1989)
    “…The synthesis and spectral properties of 2,6‐dihydroxy‐4H‐pyridazino[3,4,5‐de]quinazoline 1 are described. This compound represents the first member of a new…”
    Get full text
    Journal Article
  14. 14

    Benzoxazinones as PPARγ Agonists. 2. SAR of the Amide Substituent and In Vivo Results in a Type 2 Diabetes Model by Rybczynski, Philip J, Zeck, Roxanne E, Dudash, Joseph, Combs, Donald W, Burris, Thomas P, Yang, Maria, Osborne, Melville C, Chen, Xiaoli, Demarest, Keith T

    Published in Journal of medicinal chemistry (01-01-2004)
    “…A series of benzoxazinones has been synthesized and tested for PPARγ agonist activity. Synthetic approaches were developed to provide either racemic or chiral…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail by Allan, G F, Lombardi, E, Haynes-Johnson, D, Palmer, S, Kiddoe, M, Kraft, P, Campen, C, Rybczynski, P, Combs, D W, Phillips, A

    Published in Molecular endocrinology (Baltimore, Md.) (01-10-1996)
    “…Abstract Progesterone receptor antagonists are a promising class of therapeutic drugs indicated for the treatment of a variety of reproductive conditions…”
    Get full text
    Journal Article
  18. 18

    Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists by Xiang, Min Amy, Chen, Robert H., Demarest, Keith T., Gunnet, Joseph, Look, Richard, Hageman, William, Murray, William V., Combs, Donald W., Patel, Mona

    Published in Bioorganic & medicinal chemistry letters (07-06-2004)
    “…Spirobenzazepines as V 1a selective as well as V 1a/V 2 dual vasopressin receptor antagonists have been described. A novel series of spirobenzazepines was…”
    Get full text
    Journal Article
  19. 19

    Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions by Rybczynski, Philip J., Zeck, Roxanne E., Combs, Donald W., Turchi, Ignatius, Burris, Thomas P., Xu, Jun Z., Yang, Maria, Demarest, Keith T.

    Published in Bioorganic & medicinal chemistry letters (21-07-2003)
    “…A series of benzoxazinones was synthesized as PPARγ agonists. The compounds were obtained in seven steps, and SAR was developed by variations to the core shown…”
    Get full text
    Journal Article
  20. 20